RS

Rita Steeves

IM Immunogen: 7 patents #24 of 119Top 25%
AP Acceleron Pharma: 5 patents #13 of 55Top 25%
BH Brigham and Women's Hospital: 1 patents #847 of 1,764Top 50%
TH The Bringham And Women'S Hospital: 1 patents #1 of 30Top 4%
Johnson & Johnson: 1 patents #4,762 of 7,810Top 65%
Overall (All Time): #368,320 of 4,157,543Top 9%
13
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11951156 Methods for treating pulmonary hypertension with a ligand binding domain of a TGF-beta type II receptor Paul B. Yu, Asya Grinberg, Dianne Sako, Roselyne Castonguay, Ravindra Kumar 2024-04-09
11008377 Methods of treating a fibrotic disorder by administering transforming growth factor beta receptor II fusion polypeptides Ravindra Kumar, Asya Grinberg, Dianne Sako, Roselyne Castonguay 2021-05-18
10981973 Methods of treating a sclerotic disorder by administering a transforming growth factor beta receptor type II fusion polypeptide Ravindra Kumar, Asya Grinberg, Dianne Sako, Roselyne Castonguay 2021-04-20
10682392 Methods for treating pulmonary hypertension with a TGF-beta type II receptor-FC fusion protein Paul B. Yu, Asya Grinberg, Dianne Sako, Roselyne Castonguay, Ravindra Kumar 2020-06-16
10316076 Transforming growth factor-beta receptor type II fusion polypeptides Ravindra Kumar, Asya Grinberg, Dianne Sako, Roselyne Castonguay 2019-06-11
9809637 Transforming growth factor beta receptor II fusion polypeptides Ravindra Kumar, Asya Grinberg, Dianne Sako, Roselyne Castonguay 2017-11-07
8603483 Anti-integrin immunoconjugates, methods and uses Qiming Chen, Mohit Trikha, Robert J. Lutz, Godfrey Amphlett 2013-12-10
8388960 Elimination of heterogeneous or mixed cell population in tumors Viktor S. Goldmakher, Robert J. Lutz, Ravi V. J. Chari, Yelena Kovtun, John M. Lambert +2 more 2013-03-05
8198417 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates Ravi V. J. Chari, Walter A. Blattler 2012-06-12
8163888 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates Ravi V. J. Chari, Walter A. Blattler 2012-04-24
8137669 Elimination of heterogeneous or mixed cell population in tumors Viktor S. Goldmakher, Robert J. Lutz, Ravi V. J. Chari, Yelena Kovtun, John M. Lambert +1 more 2012-03-20
8088387 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates Ravi V. J. Chari, Walter A. Blattler 2012-01-03
7989598 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates Ravi V. J. Chari, Walter A. Blattler 2011-08-02